In a recent review, it was suggested that visfatin, omentin, leptin, ficolin-3, and fetuin-A could predict GDM during mid-stage pregnancy, whereas fetuin-B, fibroblast growth factor 21 (FGF-21), and plasminogen activator inhibitor 1 (PAI1) could be predictive of GDM in the third trimester of gestation [185]. This evidence concerns the gene AHSG and gestational diabetes.